Form 8-K - Current report:
SEC Accession No. 0000950170-25-100341
Filing Date
2025-07-30
Accepted
2025-07-30 16:40:42
Documents
10
Period of Report
2025-07-24
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K meip-20250724.htm   iXBRL 8-K 43765
  Complete submission text file 0000950170-25-100341.txt   148882

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20250724.xsd EX-101.SCH 24867
12 EXTRACTED XBRL INSTANCE DOCUMENT meip-20250724_htm.xml XML 4705
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 251167734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)